Durvalumab Becomes Newest Immunotherapy Approved for Advanced Bladder Cancer May 5, 2017December 14, 2022 Arthur N. Brodsky, PhD
Atezolizumab (Tecentriq™) Receives FDA Approval for Bladder Cancer May 19, 2016December 14, 2022 Arthur N. Brodsky, PhD